Ligand Pharmaceuticals Incorporated (LGND) stock analysis
In our weekly check, Ligand Pharmaceuticals Incorporated is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 4, red flags: 6.
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LGND.
What our checks show for LGND
Red flags
- Net debt is 13.6x a year of EBITDA (debt/equity 1.2). That limits room in a downturn and raises refinancing risk.
- The price is 119 times earnings (P/E): the market already pays for a lot of future growth.
- The stock has fallen as much as 90% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 5.1 years.
- Return on capital (ROCE) is only 1.7%.
- Pay in shares equals 116% of free cash flow: it dilutes shareholders.
Warning signs
- The net margin fell by 3.4 points over 5 years, to 20.3%: the company keeps less of each sale as profit.
- The price swings a lot: 36.7% annual volatility. Expect large ups and downs.
- The share count grew by 11.8% in 2 years: each shareholder owns a smaller slice.
- Thinly traded (about 225 thousand shares a day): buying and selling can move the price.
Strengths
- The gross margin is 107% and has risen by 32.9 points: pricing power is holding.
- Analysts expect earnings per share to grow about 112% a year over the next years.
- Analysts expect revenue to grow about 29.8% a year over the next years.
- Analysts expect the net margin to improve by 42.2 points from today's 20.3%.
- The company keeps 20.3% of its revenue as net profit.
- Free cash flow is 19.3% of revenue: cash for dividends, buybacks or growth.
Similar companies
MIRM · IBRX · CAI · BLTE · CGON · ARWR
Questions
What grade does Ligand Pharmaceuticals Incorporated (LGND) have?
In our weekly check, Ligand Pharmaceuticals Incorporated is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 4, red flags: 6. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of LGND stock?
This week's biggest flags for Ligand Pharmaceuticals Incorporated: High debt, High P/E, Deep past fall. In total 10 of 23 checks show a warning or a red flag.
What does Ligand Pharmaceuticals Incorporated do?
Ligand Pharmaceuticals Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LGND.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis